×
About 4,632 results

ALLMedicine™ Hyperkalemia Center

Research & Reviews  2,049 results

An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia.
https://doi.org/10.1080/14656566.2020.1810234
Expert Opinion on Pharmacotherapy; Takkar C, Nassar T et. al.

Sep 7th, 2020 - Hyperkalemia, defined as serum potassium level > 5.0 mEq/l, is associated with serious cardiac dysrhythmias, sudden death and increased mortality risk. It is common in patients with chronic kidney disease (CKD), diabetes (DM) and heart failure (HF...

Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improv...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448835
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine; Lindner G, Burdmann EA et. al.

Aug 27th, 2020 - Hyperkalemia is a common electrolyte disorder observed in the emergency department. It is often associated with underlying predisposing conditions, such as moderate or severe kidney disease, heart failure, diabetes mellitus, or significant tissue ...

Subthreshold Micro-Pulse Yellow Laser and Eplerenone Drug Therapy in Chronic Central Se...
https://doi.org/10.1080/08820538.2020.1809682
Seminars in Ophthalmology; Vignesh TP, Maitray A et. al.

Aug 27th, 2020 - To study the outcomes of subthreshold micropulse yellow laser (SML) and eplerenone (EP) therapy in central serous chorio-retinopathy (cCSCR). Retrospective study of 28 eyes of 27 patients undergoing SML and 20 eyes of 19 patients undergoing EP the...

Brugada phenocopy induced by consumption of yellow oleander seeds - A case report.
https://doi.org/10.1016/j.jelectrocard.2020.07.014
Journal of Electrocardiology; Gunaseelan R, Sasikumar M et. al.

Aug 25th, 2020 - Brugada phenocopy is a brugada-like pattern in ECG seen in some diseases without an inherited channelopathy. The causes of brugada phenocopy are usually reversible. Once the reversible condition resolves, the ECG pattern disappears. There are many...

Handouts for Low-Potassium Diets Disproportionately Restrict Fruits and Vegetables.
https://doi.org/10.1053/j.jrn.2020.07.001
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation; Picard K, Griffiths M et. al.

Aug 19th, 2020 - Several recent publications, including an expert summary on hyperkalemia management, have encouraged plant-based foods for patients with chronic kidney disease (CKD) and highlighted the impact of potassium additives on total potassium intake. The ...

see more →

Drugs  165 results see all →

Clinicaltrials.gov  2,281 results

Hydrochlorothiazide - hydrochlorothiazide capsule, gelatin coated-Actavis Pharma, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a3eb7294-f913-434b-896c-da028bfebc73

Sep 16th, 2020 - Hydrochlorothiazide is indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combination diuretic products, hydrochlorothiazide may be used in tho...

An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia.
https://doi.org/10.1080/14656566.2020.1810234
Expert Opinion on Pharmacotherapy; Takkar C, Nassar T et. al.

Sep 7th, 2020 - Hyperkalemia, defined as serum potassium level > 5.0 mEq/l, is associated with serious cardiac dysrhythmias, sudden death and increased mortality risk. It is common in patients with chronic kidney disease (CKD), diabetes (DM) and heart failure (HF...

Microzide - hydrochlorothiazide capsule, gelatin coated-Allergan, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49dba4a1-a0c8-4945-a816-150285aad80e

Aug 27th, 2020 - MICROZIDE is indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combination diuretic products, MICROZIDE may be used in those patients in whom ...

Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improv...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448835
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine; Lindner G, Burdmann EA et. al.

Aug 27th, 2020 - Hyperkalemia is a common electrolyte disorder observed in the emergency department. It is often associated with underlying predisposing conditions, such as moderate or severe kidney disease, heart failure, diabetes mellitus, or significant tissue ...

Subthreshold Micro-Pulse Yellow Laser and Eplerenone Drug Therapy in Chronic Central Se...
https://doi.org/10.1080/08820538.2020.1809682
Seminars in Ophthalmology; Vignesh TP, Maitray A et. al.

Aug 27th, 2020 - To study the outcomes of subthreshold micropulse yellow laser (SML) and eplerenone (EP) therapy in central serous chorio-retinopathy (cCSCR). Retrospective study of 28 eyes of 27 patients undergoing SML and 20 eyes of 19 patients undergoing EP the...

see more →

News  137 results

Low RAAS inhibitor dosing linked to MACE risk
https://www.mdedge.com/cardiology/article/214456/heart-failure/low-raas-inhibitor-dosing-linked-mace-risk?channel=39313
Bianca Nogrady

Dec 17th, 2019 - Suboptimal dosing of renin-angiotensin-aldosterone system (RAAS) inhibitors to reduce the risk of hyperkalemia could increase the risk of major adverse cardiac events (MACE) and all-cause mortality in patients with chronic kidney disease (CKD) or.

SZC passes extension test for hyperkalemia
https://www.mdedge.com/cardiology/article/214327/hypertension/szc-passes-extension-test-hyperkalemia?channel=224
Jim Kling

Dec 14th, 2019 - Treatment with sodium zirconium cyclosilicate (SZC) led to lasting improvement of hyperkalemia, according to results from an 11-month open-label extension study of the HARMONIZE randomized clinical trial. SZC selectively binds potassium ions in th.

Hyperkalemia-related treatment changes linked to death in acute HF
https://www.mdedge.com/cardiology/article/212834/heart-failure/hyperkalemia-related-treatment-changes-linked-death-acute-hf?channel=39313
Catherine Hackett

Nov 21st, 2019 - The hyperkalemia that commonly occurs in patients hospitalized for acute heart failure does not affect outcomes, but it can lead to treatment changes that can in turn raise the risk of mortality. That’s according to an analysis of data from 1,589.

Patiromer Helps CKD Patients Stay on Spironolactone
https://www.medpagetoday.com/cardiology/hypertension/82166

Sep 15th, 2019 - Patiromer (Veltassa) works as an adjunctive therapy enabling persistent spironolactone (Aldactone) use among patients with uncontrolled resistant hypertension and chronic kidney disease (CKD), according to a study in nearly 300 people. Twelve week...

Wearables for Hyperkalemia Screening: Hold the Applause?
https://www.medpagetoday.com/nephrology/generalnephrology/78995

Apr 3rd, 2019 - Applying artificial intelligence to the ECG may make it possible to screen patients with chronic kidney disease (CKD) for hyperkalemia without making them get a blood test, a study showed. Researchers trained a deep learning model to predict serum...

see more →